Related Experiment Video
Updated: Jun 12, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Combination therapy in hypertension: new recommendations
The American Hypertension Society released new guidelines on combination therapy for hypertension. This essential reading informs physicians and medical funders on effective hypertension treatment strategies.
Area of Science:
- Cardiology
- Internal Medicine
- Pharmacology
Background:
- Hypertension remains a significant global health challenge.
- Effective blood pressure management is crucial for preventing cardiovascular events.
- Combination therapy is increasingly recognized for optimizing hypertension control.
Purpose of the Study:
- To summarize the key recommendations from the American Hypertension Society (ASH) position paper.
- To highlight the importance of combination therapy in hypertension management.
- To inform healthcare providers and medical aid funders in South Africa about updated treatment guidelines.
Main Methods:
- Review of the American Hypertension Society (ASH) position paper on combination therapy.
- Analysis of current evidence supporting antihypertensive combination treatments.
- Synthesis of expert recommendations for clinical practice.
Main Results:
- The ASH position paper provides comprehensive guidance on utilizing combination therapy.
- Evidence supports the efficacy and safety of specific antihypertensive drug combinations.
- The paper emphasizes individualized treatment approaches.
Conclusions:
- The ASH position paper is a vital resource for physicians managing hypertension.
- Understanding and implementing these guidelines can improve patient outcomes.
- South African medical aid funders should consider these recommendations for formulary decisions.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Heart Failure V: Medical Management
Antihypertensive Drugs: Direct Renin Inhibitors
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...